AstraZeneca to buy biotech firm TeneoTwo for up to $1.27 billion
July 05, 2022 at 08:00 AM EDT
AstraZeneca has agreed to buy biotech firm TeneoTwo in a deal worth up to $1.27, with Non-Hodgkin's lymphoma early-stage treatment at the heart of the deal.
